New Insight into Acute Myeloid Leukemia Classification and Risk Stratification

Nahla AM Hamed
Additional contact information
Nahla AM Hamed: Faculty of Medicine, Alexandria University, Egypt

Cancer Therapy & Oncology International Journal, 2018, vol. 11, issue 2, 56-57

Abstract: AML is the most commonly occurring acute hematological malignancy in adults. It represents more than 80% of all leukemias in patients over 60 years of age. The probability of acquiring a mutation in a gene that will confer selective advantage and clonal selection in hematopoietic stem and progenitor cells increases with age. The focus of this review is to highlight on what is new in the 2016 revision to the World Health Organization classification of AML and related neoplasms. Attention to AML risk status by cytogenetics and molecular abnormalities will also be summarized.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555809.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555809.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:11:y:2018:i:2:p:56-57

DOI: 10.19080/CTOIJ.2018.11.555809

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().